Evolus (EOLS) Operating Expenses (2017 - 2026)
Evolus' (EOLS) quarterly Operating Expenses came in at $55.7 million in Q1 2026, down 9.84% YoY from $61.8 million in Q1 2025, and up 1.22% on a QoQ basis from $55.1 million in Q4 2025.
Evolus (EOLS) Operating Expenses (2017 - 2026) Analysis & Trends
Evolus (EOLS) has 10 years of Operating Expenses data on file, last reported at $55.7 million in Q1 2026.
- Quarterly Operating Expenses fell 9.84% year-over-year to $55.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $223.7 million (down 2.37% YoY) and the FY2025 annual result came in at $229.8 million, up 6.02% from the prior year.
- Operating Expenses advanced to $55.7 million in Q1 2026, from $55.1 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $64.5 million in Q2 2023 to a low of -$4.6 million in Q4 2022.
- A 5-year average of $49.7 million and a median of $55.1 million in 2025 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 1070.96% in 2022, down 108.65% in 2022.
- Tracing EOLS's Operating Expenses over 5 years: stood at -$4.6 million in 2022, then soared by 212.31% to $5.1 million in 2023, then soared by 973.2% to $54.9 million in 2024, then climbed by 0.22% to $55.1 million in 2025, then grew by 1.22% to $55.7 million in 2026.
- The last three Operating Expenses figures came in at $55.7 million (Q1 2026), $55.1 million (Q4 2025), and $57.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Evolus | 550.84 Mn | 505.67 Mn | 57.18 Mn | 61.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.72 Mn |
| Mar 31, 2026 | 55.75 Mn |
| Dec 31, 2025 | 55.07 Mn |
| Sep 30, 2025 | 57.34 Mn |
| Jun 30, 2025 | 55.53 Mn |
| Mar 31, 2025 | 61.83 Mn |
| Dec 31, 2024 | 54.95 Mn |
| Sep 30, 2024 | 57.57 Mn |
| Jun 30, 2024 | 54.77 Mn |
| Mar 31, 2024 | 49.43 Mn |
| Dec 31, 2023 | 5.12 Mn |
| Sep 30, 2023 | 63.46 Mn |
| Jun 30, 2023 | 64.46 Mn |
| Mar 31, 2023 | 53.76 Mn |
| Dec 31, 2022 | -4.56 Mn |
| Sep 30, 2022 | 51.80 Mn |
| Jun 30, 2022 | 58.51 Mn |
| Mar 31, 2022 | 49.36 Mn |
| Dec 31, 2021 | 52.69 Mn |
| Sep 30, 2021 | 45.79 Mn |